ACE inhibitors
Overview
ACE inhibitors (angiotensin-converting enzyme inhibitors) are a class of prescription medications widely used in cardiovascular and kidney care. They work by reducing the activity of the renin-angiotensin-aldosterone system (RAAS), a hormone system involved in regulating blood pressure, fluid balance, and vascular tone. Common examples include lisinopril, enalapril, ramipril, benazepril, captopril, and perindopril. These medicines are commonly used in the management of high blood pressure, heart failure, prior heart attack, and certain forms of chronic kidney disease, particularly when protein leakage in the urine is present.
ACE inhibitors are considered a foundational drug class in modern medicine because large clinical trials have shown that, in appropriate populations, they can lower blood pressure and are associated with reduced risk of major cardiovascular outcomes. Their importance extends beyond blood pressure control alone: research has shown benefits in cardiac remodeling, kidney protection, and reduction of complications in people with diabetes or vascular disease. For this reason, they are frequently discussed not only as antihypertensive agents, but also as long-term risk-modifying therapies.
Like all medications, ACE inhibitors have a distinct safety profile. Commonly discussed adverse effects include dry cough, dizziness, low blood pressure, elevated potassium, and changes in kidney function; a rare but serious reaction is angioedema, which involves swelling of deeper tissues and can become life-threatening if it affects the airway. They are generally avoided during pregnancy because of well-established fetal risks. The balance of benefit and risk depends on the clinical context, other medications being used, and underlying conditions such as kidney disease, dehydration, or bilateral renal artery stenosis.
From an integrative health perspective, ACE inhibitors are an example of a medication with a strong evidence base in conventional care, while also raising broader questions relevant to complementary medicine: how traditional systems understand hypertension and fluid regulation, how lifestyle and mind-body practices may support overall cardiovascular health, and how herbs or supplements may interact with prescription drugs. Because of the potential for clinically meaningful interactions and side effects, discussion with a qualified healthcare professional is an important part of any care plan involving ACE inhibitors.
Western Medicine Perspective
Western Medicine Perspective
In conventional medicine, ACE inhibitors are understood through their action on the angiotensin-converting enzyme, which normally converts angiotensin I to angiotensin II, a potent vasoconstrictor. By lowering angiotensin II and reducing aldosterone signaling, these medications tend to promote vasodilation, reduced sodium and water retention, and lower blood pressure. They also influence bradykinin metabolism, which may contribute to vascular benefits but is also thought to be one reason some people develop the characteristic dry cough or, rarely, angioedema.
Clinical use is based on extensive trial data and guideline recommendations. Major cardiology and nephrology guidelines recognize ACE inhibitors as important therapies in conditions such as hypertension, heart failure with reduced ejection fraction, post-myocardial infarction care, and proteinuric chronic kidney disease. Studies indicate that in selected patient groups, they can reduce hospitalization, slow progression of kidney damage, and lower the risk of cardiovascular events. Monitoring is an important part of routine use because serum creatinine and potassium can rise after initiation or dose adjustment, particularly in people with impaired kidney function, volume depletion, or concurrent use of other medications that affect the RAAS.
Conventional medicine also places strong emphasis on contraindications and interaction risks. ACE inhibitors are generally not combined with certain other RAAS-targeting drugs in many situations because of increased risk of kidney injury, hypotension, or hyperkalemia. They are also recognized as unsafe in pregnancy. In routine care, their role is typically considered alongside broader cardiovascular risk reduction strategies such as diet, physical activity, weight management, smoking cessation, and treatment of comorbid conditions, rather than as a standalone solution.
Eastern & Traditional Perspective
Eastern/Traditional Medicine Perspective
Traditional medical systems do not describe ACE inhibitors as a historical category, since they are modern pharmaceuticals. However, many Eastern and traditional frameworks have long addressed symptom patterns and constitutions that overlap with conditions for which ACE inhibitors are used today, such as elevated blood pressure, fluid retention, palpitations, headaches, dizziness, and weakness after chronic illness. In Traditional Chinese Medicine (TCM), these patterns may be interpreted through concepts such as Liver yang rising, Liver fire, phlegm-damp accumulation, Blood stasis, or Kidney deficiency, depending on the individual presentation. In Ayurveda, comparable presentations may be discussed through imbalances involving Vata, Pitta, Kapha, rakta dhatu, and medovaha srotas, especially in relation to circulation, stress, metabolism, and fluid handling.
From these perspectives, care is often framed in terms of restoring systemic balance rather than targeting a single enzyme pathway. Traditional approaches may include dietary patterns, stress regulation, breathing practices, meditation, movement therapies, herbal formulations, and individualized constitutional assessment. Naturopathic and integrative traditions similarly emphasize foundational contributors to cardiovascular health such as sleep, inflammation, vascular function, and metabolic resilience. Research into mind-body practices suggests possible supportive effects on blood pressure and stress physiology in some populations, although these findings do not make traditional systems direct substitutes for prescription cardiovascular therapy.
A key integrative consideration is herb-drug interaction potential. Herbs and supplements that influence blood pressure, kidney function, fluid balance, or potassium levels may theoretically alter the effects or risks of ACE inhibitors. For example, some botanicals, electrolyte products, or salt substitutes may complicate management by affecting blood pressure control or potassium balance. For that reason, integrative care models generally emphasize careful coordination between conventional clinicians and qualified complementary medicine practitioners, especially when prescription cardiovascular medications are involved.
Related Topics
Potassium supplements
Potassium supplements — a medication in the health ontology.
Spironolactone
Spironolactone — a medication in the health ontology.
How They Relate
ACE inhibitors & Potassium supplements
ACE inhibitors are widely used for hypertension, chronic kidney disease, and heart failure. They lower blood pressure and protect the kidneys in part by reducing angiotensin II and, downstream, ald...
ACE inhibitors & Spironolactone
ACE inhibitors and spironolactone both act on the renin–angiotensin–aldosterone system (RAAS) but at different points. ACE inhibitors block conversion of angiotensin I to angiotensin II, lowering v...
Evidence & Sources
Supported by multiple clinical trials and systematic reviews
- American Heart Association
- American College of Cardiology/American Heart Association Heart Failure Guidelines
- KDIGO Clinical Practice Guideline for Chronic Kidney Disease
- The New England Journal of Medicine
- The Lancet
- StatPearls
- National Institute for Health and Care Excellence (NICE)
- National Center for Complementary and Integrative Health (NCCIH)
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.